HOOK hookipapharma.com: Multiplikator Forward P/S
HOOKIPA Pharma Inc. (HOOK) automates the creation of immunotherapeutic vectors via closed bioreactors. On GURU.Markets, the forward P/S valuation reflects the price action, where 0.90 characterizes this valuation parameter. The company relies on partnerships with industry behemoths due to a lack of profitability. Vaccine development is limited by the R&D sector and strict FDA oversight, which determines the overall financial stability of the business.
Rincian metrik lan analitis perusahaan hookipapharma.com (HOOK)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas HOOKIPA Pharma Inc.|HOOK - Utang jangka dawa marang modal|Utang jangka cendhak marang modal HOOKIPA Pharma|HOOK - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku HOOKIPA Pharma Inc.|HOOK - Kewajiban jangka dawa|Utang jangka cendhak perusahaan HOOKIPA Pharma|Indikator likuiditas cepet hookipapharma.com
- data bathi bisnis lan rasio investasi:
HOOK - Bathi pungkasan|Bathi sing dikarepake HOOKIPA Pharma Inc.|HOOK - Kapitalisasi marang bathi resik|Pangali Forward P/E HOOKIPA Pharma|HOOK - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA HOOKIPA Pharma Inc.|HOOK - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan HOOKIPA Pharma|HOOK - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan hookipapharma.com|HOOK - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep HOOKIPA Pharma Inc.
- rincian pendapatan lan dodolan:
Analisis komprehensif perusahaan:HOOK (HOOKIPA)
This indicator determines the asset's market value relative to its projected revenue, allowing for an assessment of the fairness of the control premium and preventing illusions during local price spikes. By analyzing the expected P/S ratio, an investor can compare the current capitalization of HOOKIPA Pharma Inc. (HOOK) with the potential for vaccine commercialization and the scalability of viral vector production for mass cancer treatment.
Pesaing langsung
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|Rega forward marang dodolan ADMA (ADMA Corp)|Protagonist Therapeutics (PTGX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep immunovant.com (IMVT)|Rasio rega marang prakiraan pendapatan Kiniksa|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Grifols SA GRFS|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Multiplikator Forward P/S Celldex Corp (CLDX)|Multiplikator Forward P/S AUPH (Aurinia Pharmaceuticals)|Rasio kapitalisasi marang dodolan sing dikarepake biocryst.com (BCRX)|VERA - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan DNTH|PHVS: Multiplikator Forward P/S|AbCellera Corp (ABCL) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan TRML|PGEN: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Pharming Group (PHAR)|NKTR: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S UPB (Upstream Bio Corp)|Rega forward marang dodolan ZBIO|Immunome, Inc. - Multiplikator Forward P/S|GOSS - Multiplikator Forward P/S|KalVista Pharmaceuticals, Inc. (KALV) - Rasio rega marang prakiraan pendapatan|Septerna, Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Pieris Pharmaceuticals Inc|Multiplikator forward rega marang pendapatan Savara Pharma (SVRA)|Multiplikator Forward P/S RIGL|Multiplikator Forward P/S anaptysbio.com (ANAB)|Astria Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan ENGN|RAPT Therapeutics, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Aerovate Therapeutics Inc JBIO|Aclaris Therapeutics (ACRS) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan KYTX|TLSA (Tiziana Life Sciences Ltd) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Cabaletta Bio Inc. (CABA)|Multiplikator forward rega marang pendapatan VTYX (Ventyx Bio)|Rasio kapitalisasi marang dodolan sing dikarepake Theratechnologies, Inc|Multiplikator Forward P/S AVTX (Avalo Therapeutics, Inc)|Rega forward marang dodolan ELDN|AGEN - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Climb Bio Inc.|Zura Bio Limited (ZURA) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep aTyr Pharmaceuticals (ATYR)|Rasio rega marang prakiraan pendapatan Adagene Inc|Multiplikator Forward P/S Ikena Oncology, Inc.|Rasio rega marang prakiraan pendapatan Shattuck Labs, Inc. (STTK)|EQ: Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S CNTB (Connect Biopharma Holdings Limited)|Rega forward marang dodolan IMUX|Atara Biotherapeutics Inc - Multiplikator Forward P/S|IFRX - Multiplikator Forward P/S|X4 Pharmaceuticals, Inc. (XFOR) - Rasio rega marang prakiraan pendapatan|Adicet Bio, Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Celularity Inc|Multiplikator forward rega marang pendapatan INmune Bio Corporation (INMB)|Multiplikator Forward P/S BRNS|Multiplikator Forward P/S kezarlifesciences.com (KZR)|SAB Biotherapeutics, Inc. - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AKTX|Enlivex Therapeutics, Ltd. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Q32 Bio Inc. QTTB|GeoVax Labs, Inc. (GOVX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan edesabiotech.com|Rasio rega marang prakiraan pendapatan iBio|Multiplikator forward rega marang pendapatan Carisma Tx (CARM)|Multiplikator forward rega marang pendapatan XTLB (XTL Biopharmaceuticals, Ltd.)|Multiplikator Forward P/S boltbio.com (BOLT)|Rasio rega marang prakiraan pendapatan HCW Biologics HCWB|APVO: Kapitalisasi marang prakiraan pendapatan|AIM ImmunoTech - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aditxt|GRI: Multiplikator Forward P/S|XORTX Corp - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Vyome Holdings Inc|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep revbiosciences.com REVB|Rasio rega marang prakiraan pendapatan Indaptus Therapeutics, Inc. (INDP)|SCNI - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan CalciMedica CALI|Multiplikator Forward P/S Affimed NV AFMD|Allakos Therapeutics - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan OCEA (Ocean Biomedical Inc)|TCBP (TC BioPharm (Holdings) PLC) - Multiplikator Forward P/S|Multiplikator Forward P/S Third Harmonic Bio Inc
